Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran

authors:

avatar Seyed Moayed Alavian 1 , * , avatar Masoud Ahmadzad Asl 2 , avatar maryam keshvari 3 , avatar Bita Behnava 4 , avatar bashir hajibeigi 5

Department of Gastroenterology, Baqiyatallah University of Medical Sciences , Dean of Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
Methodology and Statistics Consultant, Nikan Health Researchers Institute, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
Infectious Specialist, Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran
Infectious Specialist, Tehran Hepatitis Center, Tehran, Tehran, IR.Iran
Blood Transfusion Research Center, Iran Blood Transfusion Organization, Tehran, Tehran, IR.Iran
Hepatitis Monthly: Vol.6, issue 1; e92946
published online: March 31, 2006
article type: Research Article
received: May 05, 2019
accepted: March 31, 2006

how to cite: Alavian S M, Ahmadzad Asl M, keshvari M, Behnava B, hajibeigi B. Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran. Hepat Mon. 2006;6(1):e92946. 

Abstract

References

  • 1.

    The references are available in the PDF file.